Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells

DSpace Repository

Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells

Author: Singha, Prosanta K.; Maklin, Kiira; Vihavainen, Taina; Laitinen, Tuomo; Nevalainen, Tapio J.; Patil, Mahadeo R.; Tonduru, Arun K.; Poso, Antti; Laitinen, Jarmo T.; Savinainen, Juha R.
Tübinger Autor(en):
Poso, Antti
Published in: European Journal of Pharmaceutical Sciences (2020), Bd. 149, Article 105321
Verlagsangabe: Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.ejps.2020.105321
ISSN: 1879-0720
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)